by Sandeep Gupta | Jul 26, 2022 | Blog
Want to learn more about STATinMED and the power of RWD Insights? Here we share some common questions, with answers about our data source and approach. Is your data source HIPAA-compliant? Yes, our data source is de-identified, tokenized, and meets the...
by Sandeep Gupta | Mar 24, 2022 | Blog
Study Purpose and Population Epidemiology of rare diseases is important for clinicians to consider, as prevalence and incidence inform the healthcare community about likelihood of disease within an at-risk population. Studies in epidemiology also help to support...
by Sandeep Gupta | Jan 31, 2022 | Blog
For years, market access teams within the biopharmaceutical industry have relied on regional, state and national medical and pharmacy covered lives data to size and scale their markets, identify targets, and set priorities for their strategy and contract negotiations....
by Sandeep Gupta | Jan 4, 2022 | Blog
Real-world data (RWD) and real-world evidence (RWE) are transforming the future of healthcare, including how Health Economics & Outcomes Research (HEOR) reveals the true burden of disease. Clinical trial data and payer-limited datasets are not enough to fully...
by Sandeep Gupta | Oct 2, 2021 | Blog
When it comes to precision medicine, advances in technologies and treatments have provided near cures for patients with previously incurable cancer, and several more options for those with genetic and immune conditions. Recognized for over a decade, testing of tumors...